Immunovant, Inc.
- Stock
- Ticker IMVT
- Nasdaq
Performance, volatility and drawdowns of Immunovant, Inc. since 12/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $39,515. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −93.6% in 06/2022, measured from the peak in 11/2020. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Net income | -111 | -106 | -121 | -127 | -111 | -148 | -153 | -97 |
| Earnings per share | -0.76 | -0.63 | -0.71 | -0.73 | -0.61 | -0.73 | -0.75 | -0.47 |
| Balance sheet | ||||||||
| Total assets | 421 | 776 | 661 | 583 | 1,052 | 957 | 852 | 761 |
| Liabilities | 68 | 69 | 53 | 63 | 66 | 104 | 117 | 104 |
| Equity | 353 | 707 | 609 | 520 | 986 | 853 | 735 | 657 |
| Cash | 375 | 714 | 599 | 522 | 995 | 902 | 798 | 722 |
| Cash flow | ||||||||
| Operating cash flow | -100 | -111 | -117 | -103 | -92 | -95 | -124 | -83 |
| Capital expenditure | -0.2 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | – | – |
| Free cash flow | -101 | -111 | -117 | -103 | -92 | -95 | -124 | -83 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +191.1%, weakest 2021 at −81.6%. 4 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$0.47 |
| 6 Aug 2026 | −$0.75 |
| 20 May 2026 | −$0.73 |
| 6 Feb 2026 | −$0.61 |
| 10 Nov 2025 | −$0.73 |
| 11 Aug 2025 | −$0.71 |
| 29 May 2025 | −$0.63 |
| 6 Feb 2025 | −$0.76 |
| 7 Nov 2024 | −$0.74 |
| 6 Aug 2024 | −$0.60 |
| 29 May 2024 | −$0.52 |
| 12 Feb 2024 | −$0.36 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €6.0bn
- Market cap in trading currency
- $6.57bn
- Enterprise value
- $5.85bn
- P/E
- –
- P/S
- –
- P/B
- 10.01
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -6.0%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$510m
- Net income
- −$509m
- Earnings per share
- −$2.56
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -86.5%
- Return on assets
- -66.9%
Balance sheet and cash flow
- Cash
- $722m
- Cash per share
- $3.49
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 7.31
- Book value per share
- $3.17
- Operating cash flow
- −$395m
- Free cash flow
- −$395m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 207m
- Volume
- 702,865
- Avg. volume 3 months
- 1.44m
- Relative volume
- 0.5
Price and technicals
- Price
- $31.77
- 1 day
- −2.3%
- 52-week high
- $44.96
- 52-week low
- $22.02
- Distance to 52-week high
- −29.3%
- Distance to 52-week low
- +44.3%
- Distance to 50-day line
- −0.9%
- Distance to 200-day line
- −2.3%
- RSI (14)
- 48
- Volatility 1M
- 69.5%
Performance
- 1 week
- −7.1%
- 1 month
- +9.2%
- 3 months
- −26.7%
- 6 months
- −7.0%
- YTD
- +25.0%
- 1 year
- +37.2%
Dates
- Fiscal year end
- 31 Mar 2026
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has IMVT performed since 12/2019?
$10,000 grew to $19,881 by 20 Nov 2026, which is +10.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is IMVT?
Volatility was 73.0% per year, measured on monthly returns. The largest decline from a peak was −93.6%, with the low in 06/2022.
How does IMVT compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.6% per year at 16.6% volatility, IMVT returned +10.4% at 73.0%. The correlation of monthly returns was 0.17; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.